Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01507987 · ClinicalTrials.gov registry record
St.Jude Medical Cardiac Lead Assessment Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,216
- Enrollment target
NCT01507987: Completed study, sponsored by Abbott Medical Devices.
NCT01507987 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,216 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01507987 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,216 participants
- Enrollment target
Study Summary
The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized, multi-center, international postmarket surveillance study under 522 Order PS120111 (August 16, 2012).
Primary Outcome
The prevalence of electrical dysfunction was calculated as the number of leads that have electrical dysfunction through three years of follow-up for the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.
Interventions
- DEVICE Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,216 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-09 |
What the finished NCT01507987 record still lists
NCT01507987 is an observational study that tracks outcomes without assigning an intervention. Its 2,216 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads is the first listed.
NCT01507987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01507987 about?
NCT01507987 is a clinical study titled "St.Jude Medical Cardiac Lead Assessment Study". The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized, multi-center, international postmarket surveillance study under 522 Order PS120111 (August 16, 2012).
What is the current status of trial NCT01507987?
This trial is currently completed. The enrollment target is 2,216 participants. The study started on 2013-03. Estimated completion is 2019-09.
What interventions are being tested in trial NCT01507987?
The interventions under investigation include: Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads (DEVICE).
Who is sponsoring clinical trial NCT01507987?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia